Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)Obesity (Silver Spring, Md.), 2013-05, Vol.21 (5), p.935-943 [Peer Reviewed Journal]Copyright © 2013 The Obesity Society ;Copyright © 2013 The Obesity Society. ;Copyright © 2013 The Obesity Society 2013 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.20309 ;PMID: 23408728Full text available |
2 |
Material Type: Article
|
![]() |
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM TrialThe journal of clinical endocrinology and metabolism, 2011-10, Vol.96 (10), p.3067-3077 [Peer Reviewed Journal]Copyright © 2011 by The Endocrine Society ;2015 INIST-CNRS ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-1256 ;PMID: 21795446 ;CODEN: JCEMAZFull text available |
3 |
Material Type: Article
|
![]() |
Evolution of pharmacological obesity treatments: focus on adverse side-effect profilesDiabetes, obesity & metabolism, 2016-06, Vol.18 (6), p.558-5702016 John Wiley & Sons Ltd ;2016 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12657 ;PMID: 26936802 ;CODEN: DOMEF6Full text available |
4 |
Material Type: Article
|
![]() |
MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and futureEuropean journal of endocrinology, 2017-06, Vol.176 (6), p.R309-R324 [Peer Reviewed Journal]2017 European Society of Endocrinology ;2017 European Society of Endocrinology. ;Copyright BioScientifica Ltd. Jun 2017 ;ISSN: 0804-4643 ;EISSN: 1479-683X ;DOI: 10.1530/EJE-16-1044 ;PMID: 28246151Full text available |
5 |
Material Type: Article
|
![]() |
Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended releaseDiabetes care, 2014-12, Vol.37 (12), p.3309-3316 [Peer Reviewed Journal]2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Dec 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-0930 ;PMID: 25249652 ;CODEN: DICAD2Full text available |
6 |
Material Type: Article
|
![]() |
Canagliflozin: Effects in overweight and obese subjects without diabetes mellitusObesity (Silver Spring, Md.), 2014-04, Vol.22 (4), p.1042-1049 [Peer Reviewed Journal]2013 The Authors Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS) ;2013 The Authors Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS). ;2013 The Authors Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS) 2013 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.20663 ;PMID: 24227660Full text available |
7 |
Material Type: Article
|
![]() |
Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet‐Induced Obese (DIO) RatsObesity (Silver Spring, Md.), 2012-08, Vol.20 (8), p.1645-1652 [Peer Reviewed Journal]2012 North American Association for the Study of Obesity (NAASO) ;Copyright Nature Publishing Group Aug 2012 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2012.59 ;PMID: 22402735Full text available |
8 |
Material Type: Article
|
![]() |
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adultsInternational Journal of Obesity, 2014-05, Vol.38 (5), p.689-697 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group May 2014 ;Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited ;ISSN: 0307-0565 ;ISSN: 1476-5497 ;EISSN: 1476-5497 ;DOI: 10.1038/ijo.2013.149 ;PMID: 23942319 ;CODEN: IJOBDPFull text available |
9 |
Material Type: Article
|
![]() |
Update on obesity pharmacotherapyAnnals of the New York Academy of Sciences, 2014-04, Vol.1311 (1), p.1-13 [Peer Reviewed Journal]2014 New York Academy of Sciences. ;ISSN: 0077-8923 ;EISSN: 1749-6632 ;DOI: 10.1111/nyas.12328 ;PMID: 24641701 ;CODEN: ANYAA9Full text available |
10 |
Material Type: Article
|
![]() |
systematic review on use of Chinese medicine and acupuncture for treatment of obesityObesity reviews, 2012-05, Vol.13 (5), p.409-430 [Peer Reviewed Journal]2012 The Authors. reviews © 2012 International Association for the Study of Obesity ;2012 The Authors. obesity reviews © 2012 International Association for the Study of Obesity. ;ISSN: 1467-7881 ;EISSN: 1467-789X ;DOI: 10.1111/j.1467-789X.2011.00979.x ;PMID: 22292480Full text available |
11 |
Material Type: Article
|
![]() |
Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity PharmacotherapyObesity (Silver Spring, Md.), 2009-09, Vol.17 (9), p.1736-1743 [Peer Reviewed Journal]2009 North American Association for the Study of Obesity (NAASO) ;2009 The Obesity Society 2009 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2009.184 ;PMID: 19521351Full text available |
12 |
Material Type: Article
|
![]() |
Cardiovascular Safety During and After Use of Phentermine and TopiramateThe journal of clinical endocrinology and metabolism, 2019-02, Vol.104 (2), p.513-522 [Peer Reviewed Journal]Copyright © 2019 Endocrine Society 2019 ;Copyright © Oxford University Press 2015 ;COPYRIGHT 2019 Oxford University Press ;Copyright © 2019 Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2018-01010 ;PMID: 30247575Full text available |
13 |
Material Type: Article
|
![]() |
Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTsObesity reviews, 2013-05, Vol.14 (5), p.383-392 [Peer Reviewed Journal]2013 The Authors. reviews © 2013 International Association for the Study of Obesity ;2013 The Authors. obesity reviews © 2013 International Association for the Study of Obesity. ;Obesity Reviews © 2013 International Association for the Study of Obesity ;ISSN: 1467-7881 ;EISSN: 1467-789X ;DOI: 10.1111/obr.12015 ;PMID: 23331711Full text available |
14 |
Material Type: Article
|
![]() |
Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysisInternational Journal of Obesity, 2019-10, Vol.43 (10), p.2085-2094 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0307-0565 ;EISSN: 1476-5497 ;DOI: 10.1038/s41366-018-0302-z ;PMID: 30664661Full text available |
15 |
Material Type: Article
|
![]() |
Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trialsObesity reviews, 2011-05, Vol.12 (5), p.e338-e347 [Peer Reviewed Journal]2011 The Authors. reviews © 2011 International Association for the Study of Obesity ;2011 The Authors. obesity reviews © 2011 International Association for the Study of Obesity. ;ISSN: 1467-7881 ;EISSN: 1467-789X ;DOI: 10.1111/j.1467-789X.2010.00846.x ;PMID: 21438989Full text available |
16 |
Material Type: Article
|
![]() |
Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibitionDiabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.125-1342015 John Wiley & Sons Ltd ;2015 John Wiley & Sons Ltd. ;2016 John Wiley & Sons Ltd ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12578 ;PMID: 26403227 ;CODEN: DOMEF6Full text available |
17 |
Material Type: Article
|
![]() |
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 yearDiabetes, obesity & metabolism, 2017-09, Vol.19 (9), p.1276ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12954Digital Resources/Online E-Resources |
18 |
Material Type: Article
|
![]() |
Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trialInternational Journal of Obesity, 2021-08, Vol.45 (8), p.1687-1695 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0307-0565 ;EISSN: 1476-5497 ;DOI: 10.1038/s41366-021-00831-4 ;PMID: 34083744Full text available |
19 |
Material Type: Article
|
![]() |
Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.439-4432016 John Wiley & Sons Ltd ;2016 John Wiley & Sons Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12636 ;PMID: 26818602 ;CODEN: DOMEF6Full text available |
20 |
Material Type: Article
|
![]() |
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trialDiabetes, obesity & metabolism, 2014-04, Vol.16 (4), p.334-3432013 John Wiley & Sons Ltd ;2013 John Wiley & Sons Ltd. ;2014 John Wiley & Sons Ltd ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12221 ;PMID: 24118885 ;CODEN: DOMEF6Full text available |